S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Log in
OTCMKTS:INND

InnerScope Hearing Technologies Stock Forecast, Price & News

$0.03
+0.01 (+66.67 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.01
Now: $0.03
$0.03
50-Day Range
$0.00
MA: $0.02
$0.07
52-Week Range
$0.00
Now: $0.03
$0.10
Volume230.12 million shs
Average Volume377.85 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
InnerScope Hearing Technologies, Inc. provides hearing aids and its hearable, and wearable personal sound amplifier products to retail hearing aid dispensing community. The company engages in the provision of manufacturing and direct-to-consumer distribution/retail of hearing aids, personal sound amplifier products, hearing related treatment therapies, doctor-formulated dietary hearing supplements, and proprietary CDB oil for treating tinnitus. It also owns and operates 11 audiological and retail hearing device clinics; and offers business to business SaaS based patient management system software program. The company was formerly known as Innerscope Advertising Agency, Inc. and changed its name to InnerScope Hearing Technologies, Inc. in August 2017. InnerScope Hearing Technologies, Inc. was incorporated in 2012 and is headquartered in Roseville, California.

Headlines

Innerscope Hearing Technologies Inc.
January 21, 2021 |  barrons.com
Innerscope Hearing Technologies Inc (INND)
November 7, 2020 |  nasdaq.com
IntriCon Corp
October 15, 2020 |  bloomberg.com
InnerScope Hearing Technologies, Inc. (INND)
March 25, 2020 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Industry Advertising Agencies
Sub-IndustryN/A
Current SymbolOTCMKTS:INND
CUSIPN/A
CIKN/A
Phone916-218-4100
Employees19
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

MarketRank

Overall MarketRank

0.50 out of 5 stars

Consumer Cyclical Sector

121st out of 223 stocks

Advertising Agencies Industry

13th out of 16 stocks

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$0.03
+0.01 (+66.67 %)
(As of 03/5/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive INND News and Ratings via Email

Sign-up to receive the latest news and ratings for INND and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











InnerScope Hearing Technologies (OTCMKTS:INND) Frequently Asked Questions

What stocks does MarketBeat like better than InnerScope Hearing Technologies?

Wall Street analysts have given InnerScope Hearing Technologies a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but InnerScope Hearing Technologies wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting InnerScope Hearing Technologies?

InnerScope Hearing Technologies saw a increase in short interest in January. As of January 29th, there was short interest totaling 272,500 shares, an increase of 415.1% from the January 14th total of 52,900 shares. Based on an average trading volume of 734,238,300 shares, the days-to-cover ratio is currently 0.0 days.
View InnerScope Hearing Technologies' Short Interest
.

How has InnerScope Hearing Technologies' stock price been impacted by Coronavirus (COVID-19)?

InnerScope Hearing Technologies' stock was trading at $0.0003 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, INND shares have increased by 8,233.3% and is now trading at $0.0250.
View which stocks have been most impacted by COVID-19
.

Who are InnerScope Hearing Technologies' key executives?

InnerScope Hearing Technologies' management team includes the following people:
  • Mr. Mark Lee Moore, Founder & Chairman (Age 57, Pay $257.53k)
  • Mr. Matthew Ross Moore, Founder, CEO, Pres, Sec. & Director (Age 33, Pay $482.73k)
  • Ms. Kimberly A. Moore, CFO, Treasurer & Director (Age 64, Pay $382.64k)
  • Mr. Doug Qualset, VP of Fin. & Chief Accountant
  • Mr. Seth Greene, Chief Marketing Officer

Who are some of InnerScope Hearing Technologies' key competitors?

What other stocks do shareholders of InnerScope Hearing Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other InnerScope Hearing Technologies investors own include Co-Diagnostics (CODX), iBio (IBIO), PharmaCyte Biotech (PMCB), SANUWAVE Health (SNWV), Sierra Oncology (SRRA), Tonix Pharmaceuticals (TNXP), Ascent Solar Technologies (ASTI), BioRestorative Therapies (BRTX), Digital Ally (DGLY) and FuelCell Energy (FCEL).

What is InnerScope Hearing Technologies' stock symbol?

InnerScope Hearing Technologies trades on the OTCMKTS under the ticker symbol "INND."

How do I buy shares of InnerScope Hearing Technologies?

Shares of INND can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is InnerScope Hearing Technologies' stock price today?

One share of INND stock can currently be purchased for approximately $0.03.

How many employees does InnerScope Hearing Technologies have?

InnerScope Hearing Technologies employs 19 workers across the globe.

What is InnerScope Hearing Technologies' official website?

The official website for InnerScope Hearing Technologies is www.innerscopeadagency.com.

How can I contact InnerScope Hearing Technologies?

The company can be reached via phone at 916-218-4100.


This page was last updated on 3/6/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.